Legacy Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Pune, Maharashtra, India, established in 2016.
2016 Pune, Maharashtra, India Active
Last Updated:
Access Report
About Legacy Pharmaceuticals Private Limited

Legacy Pharmaceuticals Private Limited, a active private limited company, was established on 29 January 2016 in Pune, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24290PN2016PTC158159. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Employing 29 professional, Its leadership includes Dhananjay Dattatray Kulkarni (Additional Director), Ram Appasaheb Magar (Additional Director), Nilesh Sharadrao Aparajit (Director). Past directors included Madhuri Santosh Jagtap, Ashok Gaikwad Madhav, Santosh Ankush Pathare. It holds ₹1.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at S No 166, Gajanan Nagar Phursungi, Pune, Maharashtra, 412307.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290PN2016PTC158159

  • Registration Number

    158159

  • Incorporation Date

    29 January 2016

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.50 Cr
  • Revenue Growth **** -10.94%
  • Profit Growth **** 24.81%
  • Ebitda **** 28.08%
  • Net Worth 32.46%
  • Total Assets **** 2.33%
Company report

Legacy Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Legacy Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Legacy Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Dhananjay Dattatray Kulkarni Additional Director 10 Jun 2021 Current
Ram Appasaheb Magar Additional Director 20 Sep 2024 Current
Nilesh Sharadrao Aparajit Director 29 Jan 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 27 Dec 2020 Past
Pramod Abcsdd Additional Director 30 Dec 2017 Past
Pramod Abcsdd Additional Director 30 Dec 2017 Past
Pramod Abcsdd Additional Director 30 Dec 2017 Past
Pramod Abcsdd Additional Director 25 Mar 2024 Past
Pramod Abcsdd Additional Director 30 Dec 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Legacy Pharmaceuticals.

Legacy Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 10.94% decrease. The company also saw a substantial improvement in profitability, with a 24.81% increase in profit. The company's net worth Soared by an impressive increase of 32.46%.

Legacy Pharmaceuticals revenue growth over time
Legacy Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -10.94%
*******
*******
*******
*******
Revenue from Operations
*******
 -10.94%
*******
*******
*******
*******
Total Assets
*******
 2.33%
*******
*******
*******
*******
Profit or Loss
*******
 24.81%
*******
*******
*******
*******
Net Worth
*******
 32.46%
*******
*******
*******
*******
EBITDA
*******
 28.08%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Legacy Pharmaceuticals?

In 2021, Legacy Pharmaceuticals had a promoter holding of 51.00% and a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹15,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 1.50 Cr
Latest Charge Details
Date Lender Amount Status
04 Sep 2024 Others ₹1.50 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Legacy Pharmaceuticals?

Legacy Pharmaceuticals has a workforce of 29 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Legacy Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Legacy Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Legacy Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Legacy Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Legacy Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was recorded as a recent event.

  • Director Appointment

    Ram Appasaheb Magar was appointed as a Additional Director was appointed as a Additional Director on 20 Sep 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 15.00 M with Charge ID 100979576 was registered on 04 Sep 2024. was documented.

  • Director Appointment

    The activity Dhananjay Dattatray Kulkarni was appointed as a Additional Director was appointed as a Additional Director on 10 Jun 2021 & has been associated with this company since 4 years 8 months . was completed.

  • Director Appointment

    Nilesh Sharadrao Aparajit was appointed as a Director was appointed as a Director on 29 Jan 2016 & has been associated with this company since 10 years 1 month . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Legacy Pharmaceuticals Private Limited?

The CIN of Legacy Pharmaceuticals Private Limited is U24290PN2016PTC158159.

Where is Legacy Pharmaceuticals Private Limited headquartered?

Legacy Pharmaceuticals Private Limited is headquartered at S No 166, Gajanan Nagar Phursungi, Pune, Maharashtra, 412307.

When was Legacy Pharmaceuticals Private Limited incorporated?

Legacy Pharmaceuticals Private Limited was incorporated on 29 January 2016.

Who are the current directors of Legacy Pharmaceuticals Private Limited?

The current directors of Legacy Pharmaceuticals Private Limited are

What is the primary industry of Legacy Pharmaceuticals Private Limited?

The primary industry of Legacy Pharmaceuticals Private Limited is Trade.

Is Legacy Pharmaceuticals Private Limited a listed company?

Legacy Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Legacy Pharmaceuticals Private Limited?

The authorized capital of Legacy Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Legacy Pharmaceuticals Private Limited?

The compliance status of Legacy Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available